The use of adalimumab for cricoarytenoid arthritis in ankylosing spondylitis-an effective therapy

2011 ◽  
Vol 121 (2) ◽  
pp. 335-338 ◽  
Author(s):  
Gauthier Desuter ◽  
Thierry Duprez ◽  
Caroline Huart ◽  
Quentin Gardiner ◽  
Gust Verbruggen
2009 ◽  
Vol 16 (2) ◽  
pp. 161
Author(s):  
Ju Kyeon Yim ◽  
Sung Dong Kwak ◽  
Jae Young Park ◽  
Jae Hong Cheon ◽  
Sung Yeol Choi ◽  
...  

BMJ ◽  
1973 ◽  
Vol 3 (5872) ◽  
pp. 145-146 ◽  
Author(s):  
J A Wojtulewski ◽  
R D Sturrock ◽  
A C Branfoot ◽  
F D Hart

CHEST Journal ◽  
1981 ◽  
Vol 80 (5) ◽  
pp. 641-643 ◽  
Author(s):  
Daniel M. Libby ◽  
W. Shain Schley ◽  
James P. Smith

1994 ◽  
Vol 120 (2) ◽  
pp. 214-216 ◽  
Author(s):  
F. R. Miller ◽  
J. R. Wanamaker ◽  
D. M. Hicks ◽  
H. M. Tucker

Author(s):  
Karvita B. Ahluwalia ◽  
Nidhi Sharma

It is common knowledge that apparently similar tumors often show different responses to therapy. This experience has generated the idea that histologically similar tumors could have biologically distinct behaviour. The development of effective therapy therefore, has the explicit challenge of understanding biological behaviour of a tumor. The question is which parameters in a tumor could relate to its biological behaviour ? It is now recognised that the development of malignancy requires an alteration in the program of terminal differentiation in addition to aberrant growth control. In this study therefore, ultrastructural markers that relate to defective terminal differentiation and possibly invasive potential of cells have been identified in human oral leukoplakias, erythroleukoplakias and squamous cell carcinomas of the tongue.


Sign in / Sign up

Export Citation Format

Share Document